Gastrointestinal microbiome

GI Microbiome - The Gut Garden

• Composition: Predominantly anaerobic bacteria. Key phyla: Bacteroidetes (G-), Firmicutes (G+). ↑Firmicutes/Bacteroidetes ratio linked to obesity.
• Core Functions:
  • Metabolic: Ferments fiber into Short-Chain Fatty Acids (SCFAs). Synthesizes Vitamin K and B vitamins (biotin, folate).
  • Immune: Competitively inhibits pathogens. Essential for maturing Gut-Associated Lymphoid Tissue (GALT).
• Dysbiosis (Imbalance):
  • Antibiotics (e.g., clindamycin) risk Clostridioides difficile overgrowth.
  • Associated with IBD, obesity, and allergies.

⭐ Butyrate, a key SCFA, is the primary fuel for colonocytes and has anti-inflammatory effects.

Core Functions - Microbial Metabolism

• Carbohydrate Fermentation:
  • Anaerobic breakdown of indigestible dietary fiber (e.g., cellulose, pectin) into Short-Chain Fatty Acids (SCFAs).
  • Key SCFAs:
    • Butyrate: Preferred energy source for colonocytes; strengthens gut barrier.
    • Propionate: Hepatic gluconeogenesis substrate.
    • Acetate: Enters peripheral circulation; used in muscle & adipose tissue.
• Vitamin Synthesis:
  • Production of essential vitamins unavailable from diet alone.
  • Includes Vitamin K (crucial for coagulation factors) and B vitamins like Biotin (B7) and Folate (B9).
• Bile Acid Metabolism:
  • Deconjugation and conversion of primary bile acids into secondary bile acids (e.g., deoxycholic acid).

⭐ Gut microbiota can metabolize and inactivate drugs, altering bioavailability. A classic example is the bacterial inactivation of Digoxin, reducing its therapeutic effect in susceptible individuals.

Dysbiosis - When Flora Fails

• Definition: Disruption of the normal gut microbial community's composition, function, or diversity, often triggered by antibiotics, diet, or illness.
• Classic Example: Clostridioides difficile Infection
  • Antibiotic use (esp. clindamycin, cephalosporins, fluoroquinolones) depletes protective flora, allowing C. diff overgrowth.
  • Toxin A (enterotoxin) and Toxin B (cytotoxin) lead to mucosal injury, inflammation, and formation of pseudomembranes.
  • Results in profuse, watery diarrhea, abdominal cramping, and potential toxic megacolon.
• Therapeutic Interventions
  • Probiotics: Administration of live beneficial bacteria (e.g., Lactobacillus).
  • Prebiotics: Substrates (e.g., inulin) that promote growth of beneficial bacteria.
  • Fecal Microbiota Transplant (FMT): Highly effective for recurrent C. diff by restoring a healthy, diverse microbiome.

⭐ Diagnosis of C. difficile relies on detecting toxins A/B in the stool via enzyme immunoassay (EIA) or nucleic acid amplification tests (NAAT).

Therapeutics - Gut Reset Button

• Antibiotics: Broad-spectrum use disrupts flora → dysbiosis, ↑ risk of C. difficile infection (CDI).
• Probiotics: Live beneficial bacteria (Lactobacillus, Bifidobacterium) to restore balance. Limited efficacy for severe dysbiosis.
• Prebiotics: Dietary fibers (e.g., inulin) that fuel beneficial microbes, promoting a healthy gut environment.
• Fecal Microbiota Transplant (FMT): Infusion of stool from a healthy donor to restore a complex, healthy microbiome.

⭐ Fecal Microbiota Transplant (FMT) is a highly effective therapy for recurrent Clostridioides difficile infection, with cure rates often exceeding 90%.

• Anaerobes like Bacteroides and Clostridium are the most predominant organisms in the colon.
• Gut flora are a primary source of Vitamin K and several B vitamins.
• They are essential for the metabolism of bile acids and the breakdown of bilirubin.
• Provide colonization resistance against pathogens, most notably C. difficile.
• Crucial for the development and maturation of gut-associated lymphoid tissue (GALT).
• Antibiotic use disrupts this barrier, increasing infection risk.